234 related articles for article (PubMed ID: 19176945)
1. Body mass index and body composition in adolescents treated with gonadotropin-releasing hormone analogue triptorelin depot for central precocious puberty: data at near final height.
Chiocca E; Dati E; Baroncelli GI; Mora S; Parrini D; Erba P; Bertelloni S
Neuroendocrinology; 2009; 89(4):441-7. PubMed ID: 19176945
[TBL] [Abstract][Full Text] [Related]
2. Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment.
Poomthavorn P; Suphasit R; Mahachoklertwattana P
Gynecol Endocrinol; 2011 Aug; 27(8):524-8. PubMed ID: 21501002
[TBL] [Abstract][Full Text] [Related]
3. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
Ságodi L; Sólyom E; Lombay B; Almási A; Vámosi I
Orv Hetil; 2012 Mar; 153(11):418-24. PubMed ID: 22390866
[TBL] [Abstract][Full Text] [Related]
4. Growth, bone maturation and height prediction after three years of therapy with the slow release GnRH-agonist Decapeptyl-Depot in children with central precocious puberty.
Hümmelink R; Oostdijk W; Partsch CJ; Odink RJ; Drop SL; Sippell WG
Horm Metab Res; 1992 Mar; 24(3):122-6. PubMed ID: 1533604
[TBL] [Abstract][Full Text] [Related]
5. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
Paterson WF; McNeill E; Young D; Donaldson MD
Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
[TBL] [Abstract][Full Text] [Related]
6. Time to menarche and final height after histrelin implant treatment for central precocious puberty.
Gillis D; Karavani G; Hirsch HJ; Strich D
J Pediatr; 2013 Aug; 163(2):532-6. PubMed ID: 23485026
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a monthly compared to 3-monthly depot GnRH analogue (goserelin) in the treatment of children with central precocious puberty.
Isaac H; Patel L; Meyer S; Hall CM; Cusick C; Price DA; Clayton PE
Horm Res; 2007; 68(4):157-63. PubMed ID: 17356292
[TBL] [Abstract][Full Text] [Related]
8. [Impact of gonadotropin-releasing hormone analogs on body mass index in girls with idiopathic central precocious puberty: a long-term follow-up study].
Yuan JN; Liang L; Cai XD; Li Z; Bai M; Gu CP
Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov; 13(11):896-9. PubMed ID: 22099200
[TBL] [Abstract][Full Text] [Related]
9. Long-acting GnRH analogue triptorelin therapy in central isosexual precocious puberty.
Bajpai A; Sharma J; Kabra M; Gupta AK; Menon PS
Indian Pediatr; 2002 Jul; 39(7):633-9. PubMed ID: 12147888
[TBL] [Abstract][Full Text] [Related]
10. [Impact of gonadotropin-releasing hormone analogs treatment on final height in girls with central precocious puberty].
Chen SK; Fan X; Tang Q
Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):374-6. PubMed ID: 19470261
[TBL] [Abstract][Full Text] [Related]
11. Does GnRH analog improve the final height in Thai girls with idiopathic central precocious puberty?
Wacharasindhu S; Srivuthana S; Aroonparkmongkol S; Trinavarat P
J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S51-6. PubMed ID: 11529380
[TBL] [Abstract][Full Text] [Related]
12. Growth outcome during GnRH agonist treatments for slowly progressive central precocious puberty.
Massart F; Federico G; Harrell JC; Saggese G
Neuroendocrinology; 2009; 90(3):307-14. PubMed ID: 19641297
[TBL] [Abstract][Full Text] [Related]
13. Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function.
Heger S; Müller M; Ranke M; Schwarz HP; Waldhauser F; Partsch CJ; Sippell WG
Mol Cell Endocrinol; 2006 Jul; 254-255():217-20. PubMed ID: 16757104
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function.
Heger S; Partsch CJ; Sippell WG
J Clin Endocrinol Metab; 1999 Dec; 84(12):4583-90. PubMed ID: 10599723
[TBL] [Abstract][Full Text] [Related]
15. Treatment of central precocious puberty by GnRH analogs: long-term outcome in men.
Bertelloni S; Mul D
Asian J Androl; 2008 Jul; 10(4):525-34. PubMed ID: 18478155
[TBL] [Abstract][Full Text] [Related]
16. Initial growth deceleration during GnRH analogue therapy for precocious puberty.
Mouat F; Hofman PL; Jefferies C; Gunn AJ; Cutfield WS
Clin Endocrinol (Oxf); 2009 May; 70(5):751-6. PubMed ID: 19178517
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of combined treatment with growth hormone and gonadotropin releasing hormone analogue in children with poor prognosis of adult height.
Toumba M; Bacopoulou I; Savva SC; Skordis N
Indian Pediatr; 2007 Jul; 44(7):497-502. PubMed ID: 17684302
[TBL] [Abstract][Full Text] [Related]
18. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females.
Bertelloni S; Baroncelli GI; Sorrentino MC; Perri G; Saggese G
Eur J Pediatr; 1998 May; 157(5):363-7. PubMed ID: 9625331
[TBL] [Abstract][Full Text] [Related]
19. Combined use of growth hormone and gonadotropin-releasing hormone analogue in short normal adolescent girls: a survey from Iran.
Karamizadeh Z; Kashef MA; Jalaeian H; Namazee N
Kaohsiung J Med Sci; 2006 Apr; 22(4):161-5. PubMed ID: 16679296
[TBL] [Abstract][Full Text] [Related]
20. Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty.
Palmert MR; Mansfield MJ; Crowley WF; Crigler JF; Crawford JD; Boepple PA
J Clin Endocrinol Metab; 1999 Dec; 84(12):4480-8. PubMed ID: 10599706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
